Literature DB >> 23466079

Abciximab during percutaneous coronary intervention for ST-segment elevation myocardial infarction: intracoronary, intravenous, or not at all?

John A Bittl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23466079     DOI： 10.1016/j.jacc.2013.01.042

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  2 in total

Review 1.  Abciximab in the management of acute myocardial infarction with ST-segment elevation: evidence-based treatment, current clinical use, and future perspectives.

Authors:  Artur Dziewierz; Tomasz Rakowski; Dariusz Dudek
Journal:  Ther Clin Risk Manag       Date:  2014-07-18       Impact factor: 2.423

2.  Effect of Intravenous Abciximab on Coronary Flow Improvement After Re-vascularization in Primary Coronary Intervention and Short Term Impact.

Authors:  Ahmed N Rgeeb; Hussein A Alsalkh; Ali Kadhim Radhi; Khalid Amber
Journal:  Med Arch       Date:  2020-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.